75 related articles for article (PubMed ID: 9465528)
1. Status of ammonia, glutamate, lactate and pyruvate during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Agarwal A; Tripathi LM; Pandey VC
J Commun Dis; 1997 Sep; 29(3):235-41. PubMed ID: 9465528
[TBL] [Abstract][Full Text] [Related]
2. Status of urea and related enzymes during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Agrawal A; Tripathi LM; Pandey VC
Indian J Exp Biol; 1997 Nov; 35(11):1194-7. PubMed ID: 9567749
[TBL] [Abstract][Full Text] [Related]
3. Studies on hepatic mitochondrial cytochrome P-450 during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Srivastava P; Pandey VC
Ecotoxicol Environ Saf; 2000 May; 46(1):19-22. PubMed ID: 10805988
[TBL] [Abstract][Full Text] [Related]
4. Studies on ammonia-metabolizing enzymes during Plasmodium yoelii infection and pyrimethamine treatment in mice.
Agrawal A; Tripathi LM; Puri SK; Pandey VC
Int J Parasitol; 1996 Apr; 26(4):451-5. PubMed ID: 8773535
[TBL] [Abstract][Full Text] [Related]
5. Cerebral ammonia levels and enzyme changes during Plasmodium yoelii infection in mice.
Sharma MC; Tripathi LM; Sagar P; Dutta GP; Pandey VC
J Trop Med Hyg; 1992 Dec; 95(6):410-5. PubMed ID: 1361009
[TBL] [Abstract][Full Text] [Related]
6. Pyrimethamine induces oxidative stress in Plasmodium yoelii 17XL-infected mice: a novel immunomodulatory mechanism of action for an old antimalarial drug?
Legorreta-Herrera M; Retana-Ugalde R; Ventura-Gallegos JL; Narváez V
Exp Parasitol; 2010 Nov; 126(3):381-8. PubMed ID: 20193682
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice.
Neerja J; Puri SK
Exp Parasitol; 2004; 107(3-4):120-4. PubMed ID: 15363937
[TBL] [Abstract][Full Text] [Related]
8. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
[TBL] [Abstract][Full Text] [Related]
9. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice.
Siddiqi NJ; Alhomida AS
In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052
[TBL] [Abstract][Full Text] [Related]
10. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
11. Studies on drug metabolizing enzymes during arteether treatment of Plasmodium yoelii nigeriensis infected mice cerebral microvessels.
Agrawal A
J Commun Dis; 2005 Mar; 37(1):44-50. PubMed ID: 16637400
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory role of chloroquine and pyrimethamine in Plasmodium yoelii 17XL infected mice.
Ramos-Avila A; Ventura-Gallegos JL; Zentella-Dehesa A; Machuca-Rodríguez C; Moreno-Altamirano MM; Narváez V; Legorreta-Herrera M
Scand J Immunol; 2007 Jan; 65(1):54-62. PubMed ID: 17212767
[TBL] [Abstract][Full Text] [Related]
13. Ammonia effects on pyruvate/lactate production in astrocytes--interaction with glutamate.
Kala G; Hertz L
Neurochem Int; 2005 Jul; 47(1-2):4-12. PubMed ID: 15890434
[TBL] [Abstract][Full Text] [Related]
14. Within-host selection of drug resistance in a mouse model of repeated interrupted treatment of Plasmodium yoelii infection.
Nuralitha S; Siregar JE; Syafruddin D; Hoepelman AIM; Marzuki S
Malar J; 2017 May; 16(1):216. PubMed ID: 28535797
[TBL] [Abstract][Full Text] [Related]
15. Effect of Plasmodium yoelii nigeriensis infection on hepatic and splenic glutathione-S-transferase(s) in Swiss albino and db/+ mice: efficacy of mefloquine and menadione in antimalarial chemotherapy.
Ahmad R; Srivastava AK
Parasitology; 2007 Jul; 134(Pt 7):931-8. PubMed ID: 17352848
[TBL] [Abstract][Full Text] [Related]
16. Early treatment during a primary malaria infection modifies the development of cross immunity.
Legorreta-Herrera M; Ventura-Ayala ML; Licona-Chávez RN; Soto-Cruz I; Hernández-Clemente FF
Parasite Immunol; 2004 Jan; 26(1):7-17. PubMed ID: 15198641
[TBL] [Abstract][Full Text] [Related]
17. Glucose transport in cerebral microvessels during Plasmodium yoelii nigeriensis infection in mice.
Agrawal A; Pandey VC
J Commun Dis; 2000 Jun; 32(2):109-16. PubMed ID: 11198395
[TBL] [Abstract][Full Text] [Related]
18. Effect of hypervolaemic haemodilution on cerebral glutamate, glycerol, lactate and free radicals in heatstroke rats.
Chang CK; Chiu WT; Chang CP; Lin MT
Clin Sci (Lond); 2004 May; 106(5):501-9. PubMed ID: 14686877
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
Puri SK; Singh N
Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
